tiprankstipranks
Trending News
More News >
IRLAB Therapeutics AB Class A (SE:IRLAB.A)
:IRLAB.A
Sweden Market
Advertisement

IRLAB Therapeutics AB Class A (IRLAB.A) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

IRLAB.A Financial Forecast

IRLAB.A Earnings Forecast

The previous quarter’s earnings for IRLAB.A were -kr0.62.
The previous quarter’s earnings for IRLAB.A were -kr0.62.

IRLAB.A Sales Forecast

The previous quarter’s earnings for IRLAB.A were kr4.36M.
The previous quarter’s earnings for IRLAB.A were kr4.36M.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

IRLAB.A Analyst Recommendation Trends

Rating
May 25
Jun 25
Strong Buy
0
0
Buy
0
0
Hold
1
4
Sell
0
0
Strong Sell
0
0
total
1
4
In the current month, IRLAB.A has received 0 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. IRLAB.A average Analyst price target in the past 3 months is 6.48.
Each month's total comprises the sum of three months' worth of ratings.

IRLAB.A Stock Forecast FAQ

What is SE:IRLAB.A’s average 12-month price target, according to analysts?
Based on analyst ratings, IRLAB Therapeutics AB Class A’s 12-month average price target is 6.48.
    What is SE:IRLAB.A’s upside potential, based on the analysts’ average price target?
    IRLAB Therapeutics AB Class A has 101.32% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is IRLAB Therapeutics AB Class A a Buy, Sell or Hold?
          IRLAB Therapeutics AB Class A has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is IRLAB Therapeutics AB Class A’s share price target?
            The average share price target for IRLAB Therapeutics AB Class A is 6.48. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is kr6.48 ,and the lowest forecast is kr6.48. The average share price target represents 101.32% Increase from the current price of kr3.22.
              What do analysts say about IRLAB Therapeutics AB Class A?
              IRLAB Therapeutics AB Class A’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of IRLAB Therapeutics AB Class A?
                To buy shares of SE:IRLAB.A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis